Istvan Tornai
Debrecen, HB 4032, Hungary
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 38 publications
Longitudinal Comparison of Currently Used Risk Scores for Prognostication of Primary Sclerosing Cholangitis (PSC) in a Hungarian Bicenter PSC Cohort.
Journal: Diagnostics (Basel, Switzerland)
Published: July 22, 2025
Serum Villin-1-A Novel Marker of Gut Barrier Damage in Acutely Decompensated Cirrhosis: A Cohort Study and Validation.
Journal: Alimentary pharmacology & therapeutics
Published: April 28, 2025
Secretory IgA Is a Key Marker Among Gut Barrier Dysfunction-Related Immunoglobulins Predicting Outcomes in ACLF.
Journal: Liver international : official journal of the International Association for the Study of the Liver
Published: February 11, 2025
Long Term Follow-Up of Patients with Cryoglobulinemia After Successful Treatment of Chronic C Virus Hepatitis.
Journal: Digestive diseases and sciences
Published: January 15, 2025
Venetoclax Plus CyBorD Induction Therapy and Venetoclax Maintenance Treatment for Immunoglobulin Light Chain Amyloidosis with t(11;14) Translocation.
Journal: Current oncology (Toronto, Ont.)
Published: December 18, 2024
Abnormal ferritin levels predict development of poor outcomes in cirrhotic outpatients: a cohort study.
Journal: BMC gastroenterology
Published: December 17, 2020
Major Changes of von Willebrand Factor Multimer Distribution in Cirrhotic Patients with Stable Disease or Acute Decompensation.
Journal: Thrombosis and haemostasis
Published: July 05, 2018
Screening, diagnosis, treatment, and follow up of hepatitis C virus related liver disease. National consensus guideline in Hungary from 22 September 2017
Journal: Orvosi hetilap
Published: February 27, 2018
Ombitasvir/paritaprevir/ritonavir + dasabuvir + ribavirin in HCV genotype 1 infected patients who failed previous protease inhibitor therapy.
Journal: Clinical and experimental hepatology
Published: November 09, 2017
Loss of tolerance to gut immunity protein, glycoprotein 2 (GP2) is associated with progressive disease course in primary sclerosing cholangitis.
Journal: Scientific reports
Published: August 29, 2017
Functional polymorphisms of innate immunity receptors are not risk factors for the non-SBP type bacterial infections in cirrhosis.
Journal: Liver international : official journal of the International Association for the Study of the Liver
Published: August 14, 2017
Last Updated: 09/26/2026